ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,988Medicare Part D Prescriptions Filled, Including Refills

Rank: 282 out of 1107

$638K Total Retail Price of All Prescriptions

Rank: 267 out of 1107

502 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 8,750 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 550 343 S3 1 1
SIMVASTATIN 363 307 2 5
WARFARIN SODIUM 309 274 3 15
LISINOPRIL 256 209 4 2
OMEPRAZOLE 253 173 5 4
LEVOTHYROXINE SODIUM 250 196 6 3
METOPROLOL TARTRATE 240 200 7 10
FUROSEMIDE 231 217 8 7
HYDROCHLOROTHIAZIDE 229 179 9 11
AMLODIPINE BESYLATE 224 191 10 6
ATORVASTATIN CALCIUM 222 191 11 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 203 141 12 24
GABAPENTIN 192 132 13 9
METFORMIN HCL 181 142 14 8
POTASSIUM CHLORIDE 174 165 15 14
PANTOPRAZOLE SODIUM 147 121 16 30
METOPROLOL SUCCINATE 138 121 17 16
ZOLPIDEM TARTRATE 134 97 18 22
PRAVASTATIN SODIUM 131 98 19 12
DONEPEZIL HCL 119 119 20 32
CLOPIDOGREL 111 98 21 28
MIRTAZAPINE 107 90 22 61
ATENOLOL 96 89 23 19
MUPIROCIN 89 82 24 161
ALLOPURINOL 87 74 25 36
RANITIDINE HCL 86 48 26 21
FLUOXETINE HCL 78 41 27 47
SERTRALINE HCL 78 59 27 20
DIGOXIN 76 76 29 52
TRAMADOL HCL 73 57 30 26
CARVEDILOL 72 69 31 27
CITALOPRAM HBR 69 67 32 17
DIOVAN 68 68 33 51
PLAVIX 67 53 34 39
ADVAIR DISKUS 66 41 35 54
PROMETHAZINE HCL 63 38 R 36 44
GLIPIZIDE 63 56 36 64
SANTYL 63 58 36 255
ESCITALOPRAM OXALATE 60 46 39 82
FLUTICASONE PROPIONATE 60 53 39 38
TRAZODONE HCL 59 44 41 33
NEXIUM 58 40 42 18
CRESTOR 58 45 42 23
NAMENDA 57 57 44 42
AMLODIPINE BESYLATE-BENAZEPRIL 57 56 44 77
ONGLYZA 56 44 46 205
ISOSORBIDE MONONITRATE ER 56 38 46 34
ALPRAZOLAM 55 44 48 87
AZITHROMYCIN 55 44 48 35
CLONIDINE HCL 55 42 48 53
GLIMEPIRIDE 54 54 51 43
MELOXICAM 54 54 51 25
TAMSULOSIN HCL 53 30 53 30
DICLOFENAC SODIUM 52 31 54 74
HYDRALAZINE HCL 52 32 54 99
LOVASTATIN 52 39 54 55
PAROXETINE HCL 51 40 57 45
QUETIAPINE FUMARATE 50 50 58 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.